Creative Antibiotics AB (OSTO:CAS) Capital Expenditure : kr0.00 Mil (TTM As of Mar. 2013)

View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Creative Antibiotics AB's cash flow for capital expenditures for the three months ended in Mar. 2013 was kr0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2013 was kr0.00 Mil.

Creative Antibiotics AB Capital Expenditure Historical Data

The historical data trend for Creative Antibiotics AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Capital Expenditure Chart

Creative Antibiotics AB Annual Data

Trend

Jun08

Jun09

Jun10

Dec11

Capital Expenditure

-0.22

-0.51

Creative Antibiotics AB Quarterly Data
	Jun08	Mar09	Jun09	Sep09	Dec09	Mar10	Sep10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Mar13
Capital Expenditure	Get a 7-Day Free Trial										-	-	-	-	-

Creative Antibiotics AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.